Nyumbani › Leukemia ya Limfosaiti ya Muda Mrefu › Oklahoma
Majaribio ya kliniki ya Leukemia ya Limfosaiti ya Muda Mrefu katika jimbo la Oklahoma
Masomo 4 ya Leukemia ya Limfosaiti ya Muda Mrefu yanatafuta washiriki katika vituo vya jimbo la Oklahoma.
Miji katika jimbo la Oklahoma
Maandishi rasmi ya utafiti (Kiingereza)
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
- University of Oklahoma Health Sciences Center, Oklahoma City
InaajiriHatua 3
Umri 65 na zaidi · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT07321652Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mercy Hospital Oklahoma City, Oklahoma City
InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
Umri 40 hadi 75 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT05334069Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
- University of Oklahoma Health Sciences Center, Oklahoma City
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT04269902A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
- Oklahoma Cancer Specialists and Research Institute /ID# 267643, Tulsa
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 9 Apr 2026 · NCT06428019Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.